Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 331


Instrumented version of the modified dynamic gait index in subjects with neurological disorders.

Anastasi D, Carpinella I, Gervasoni E, Matsuda PN, Bovi G, Ferrarin M, Cattaneo D.

PM R. 2019 Feb 8. doi: 10.1002/pmrj.12137. [Epub ahead of print]


EDA fibronectin-TLR4 axis sustains megakaryocyte expansion and inflammation in bone marrow fibrosis.

Malara A, Gruppi C, Abbonante V, Cattaneo D, De Marco L, Massa M, Iurlo A, Gianelli U, Balduini CL, Tira ME, Muro AF, Chauhan AK, Rosti V, Barosi G, Balduini A.

J Exp Med. 2019 Feb 7. pii: jem.20181074. doi: 10.1084/jem.20181074. [Epub ahead of print]


Flow Cytometry Assessment of CD26+ Leukemic Stem Cells in Peripheral Blood: A Simple and Rapid New Diagnostic Tool for Chronic Myeloid Leukemia.

Raspadori D, Pacelli P, Sicuranza A, Abruzzese E, Iurlo A, Cattaneo D, Gozzini A, Galimberti S, Baratè C, Pregno P, Nicolosi M, Sorà F, Annunziata M, Luciano L, Caocci G, Moretti S, Sgherza N, Fozza C, Russo S, Usala E, Liberati MA, Ciofini S, Trawinska MM, Gozzetti A, Bocchia M.

Cytometry B Clin Cytom. 2019 Feb 3. doi: 10.1002/cyto.b.21764. [Epub ahead of print]


How much does balance and muscle strength impact walking in persons with multiple sclerosis? - A cross-sectional study.

Callesen J, Dalgas U, Brincks J, Cattaneo D.

Mult Scler Relat Disord. 2019 Jan 24;29:137-144. doi: 10.1016/j.msard.2019.01.034. [Epub ahead of print]


Clinical correlates of 9-hole peg test in a large population of people with multiple sclerosis.

Solaro C, Cattaneo D, Brichetto G, Castelli L, Tacchino A, Gervasoni E, Prosperini L.

Mult Scler Relat Disord. 2019 Jan 28;30:1-8. doi: 10.1016/j.msard.2019.01.043. [Epub ahead of print]


Drug-drug interactions of a two-drug regimen of dolutegravir and lamivudine for HIV treatment.

Cattaneo D, Capetti A, Rizzardini G.

Expert Opin Drug Metab Toxicol. 2019 Mar;15(3):245-252. doi: 10.1080/17425255.2019.1577821. Epub 2019 Feb 11.


Different effects of glucocorticoids on darunavir plasma concentrations.

Cattaneo D, Cheli S, Fusi M, Clementi E, Gervasoni C.

Eur J Clin Pharmacol. 2019 Jan 9. doi: 10.1007/s00228-019-02626-z. [Epub ahead of print] No abstract available.


Predictors of mobility domain of health-related quality of life after rehabilitation in Parkinson's disease: a pilot study.

Bowman T, Gervasoni E, Parelli R, Jonsdottir J, Ferrarin M, Cattaneo D, Carpinella I.

Arch Physiother. 2018 Dec 27;8:10. doi: 10.1186/s40945-018-0051-2. eCollection 2018.


Differences in presenting features, outcome and prognostic models in patients with primary myelofibrosis and post-polycythemia vera and/or post-essential thrombocythemia myelofibrosis treated with ruxolitinib. New perspective of the MYSEC-PM in a large multicenter study.

Palandri F, Palumbo GA, Iurlo A, Polverelli N, Benevolo G, Breccia M, Abruzzese E, Tiribelli M, Bonifacio M, Tieghi A, Isidori A, Martino B, Sgherza N, D'Adda M, Bergamaschi M, Crugnola M, Cavazzini F, Bosi C, Binotto G, Auteri G, Latagliata R, Ibatici A, Scaffidi L, Penna D, Cattaneo D, Soci F, Trawinska M, Russo D, Cuneo A, Semenzato G, Di Raimondo F, Aversa F, Lemoli RM, Heidel F, Reggiani MLB, Bartoletti D, Cavo M, Catani L, Vianelli N.

Semin Hematol. 2018 Oct;55(4):248-255. doi: 10.1053/j.seminhematol.2018.05.013. Epub 2018 Jun 5.


Impact of comorbidities and body mass index in patients with myelofibrosis treated with ruxolitinib.

Breccia M, Bartoletti D, Bonifacio M, Palumbo GA, Polverelli N, Abruzzese E, Bergamaschi M, Tieghi A, Tiribelli M, Iurlo A, Cavazzini F, Sgherza N, Binotto G, Isidori A, D'Adda M, Crugnola M, Bosi C, Heidel F, Molica M, Scaffidi L, Cattaneo D, Latagliata R, Auteri G, Lemoli RM, Fanin R, Russo D, Aversa F, Cuneo A, Semenzato G, Catani L, Cavo M, Vianelli N, Foà R, Palandri F.

Ann Hematol. 2018 Dec 4. doi: 10.1007/s00277-018-3569-1. [Epub ahead of print]


Darunavir Population Pharmacokinetic Model Based on HIV Outpatient Data.

Daskapan A, Tran QTD, Cattaneo D, Gervasoni C, Resnati C, Stienstra Y, Bierman WFW, Kosterink JGW, van der Werf TS, Proost JH, Alffenaar JC, Touw DJ.

Ther Drug Monit. 2019 Feb;41(1):59-65. doi: 10.1097/FTD.0000000000000576.


Instrumental Assessment of Stair Ascent in People With Multiple Sclerosis, Stroke, and Parkinson's Disease: A Wearable-Sensor-Based Approach.

Carpinella I, Gervasoni E, Anastasi D, Lencioni T, Cattaneo D, Ferrarin M.

IEEE Trans Neural Syst Rehabil Eng. 2018 Dec;26(12):2324-2332. doi: 10.1109/TNSRE.2018.2881324. Epub 2018 Nov 14.


Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy.

Giacomelli A, Riva A, Falvella FS, Oreni ML, Cattaneo D, Cheli S, Renisi G, Di Cristo V, Lupo A, Clementi E, Rusconi S, Galli M, Ridolfo AL.

BMC Infect Dis. 2018 Nov 12;18(1):556. doi: 10.1186/s12879-018-3462-5.


Pharmacokinetics and Pharmacodynamics of Cabotegravir, a Long-Acting HIV Integrase Strand Transfer Inhibitor.

Cattaneo D, Gervasoni C.

Eur J Drug Metab Pharmacokinet. 2018 Nov 1. doi: 10.1007/s13318-018-0526-2. [Epub ahead of print]


Clinical validity of novel postural stabilization experimental indices based on hyperbolic transformation.

Rabuffetti M, Lencioni T, Cattaneo D, Zemp DD, Quadri P, Ferrarin M.

Gait Posture. 2019 Jan;67:147-150. doi: 10.1016/j.gaitpost.2018.09.024. Epub 2018 Sep 25.


A three-in-one, long-acting, nanosuspension reformulation of off-patent antiretrovirals for low-income and middle-income countries.

Cattaneo D, Perno CF, Rizzardini G.

AIDS. 2018 Nov 13;32(17):2625-2627. doi: 10.1097/QAD.0000000000001970. No abstract available.


Responsiveness and meaningful improvement of mobility measures following MS rehabilitation.

Baert I, Smedal T, Kalron A, Rasova K, Heric-Mansrud A, Ehling R, Elorriaga Minguez I, Nedeljkovic U, Tacchino A, Hellinckx P, Adriaenssens G, Stachowiak G, Gusowski K, Cattaneo D, Borgers S, Hebert J, Dalgas U, Feys P.

Neurology. 2018 Nov 13;91(20):e1880-e1892. doi: 10.1212/WNL.0000000000006532. Epub 2018 Oct 17.


Intensive Multimodal Training to Improve Gait Resistance, Mobility, Balance and Cognitive Function in Persons With Multiple Sclerosis: A Pilot Randomized Controlled Trial.

Jonsdottir J, Gervasoni E, Bowman T, Bertoni R, Tavazzi E, Rovaris M, Cattaneo D.

Front Neurol. 2018 Sep 28;9:800. doi: 10.3389/fneur.2018.00800. eCollection 2018.


Modified Functional Walking Categories and participation in people with multiple sclerosis.

Bertoni R, Jonsdottir J, Feys P, Lamers I, Cattaneo D.

Mult Scler Relat Disord. 2018 Nov;26:11-18. doi: 10.1016/j.msard.2018.08.031. Epub 2018 Aug 31.


Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy.

Dilena R, DiFrancesco JC, Soldovieri MV, Giacobbe A, Ambrosino P, Mosca I, Galli MA, Guez S, Fumagalli M, Miceli F, Cattaneo D, Darra F, Gennaro E, Zara F, Striano P, Castellotti B, Gellera C, Varesio C, Veggiotti P, Taglialatela M.

Neurotherapeutics. 2018 Oct;15(4):1112-1126. doi: 10.1007/s13311-018-0657-9.


Counteracting Postural Perturbations Through Body Weight Shift: a Pilot Study Using a Robotic Platform in Subjects with Parkinson's Disease.

Carpinella I, Nardone A, Bonora G, Bowman T, Cattaneo D, Rabuffetti M, Ferrarin M.

IEEE Trans Neural Syst Rehabil Eng. 2018 Aug 2. doi: 10.1109/TNSRE.2018.2862463. [Epub ahead of print]


Loss of Control of HIV Viremia With OTC Weight-Loss Drugs: A Call for Caution?

Cattaneo D, Giacomelli A, Gervasoni C.

Obesity (Silver Spring). 2018 Aug;26(8):1251-1252. doi: 10.1002/oby.22240. Epub 2018 Aug 1.


Evaluation of the concentrations of psychotropic drugs in HIV-infected versus HIV-negative patients: Potential implications for clinical practice.

Cattaneo D, Baldelli S, Resnati C, Giacomelli A, Meraviglia P, Minisci D, Astuti N, Ridolfo A, De Socio GV, Clementi E, Galli M, Gervasoni C.

World J Biol Psychiatry. 2018 Sep 20:1-7. doi: 10.1080/15622975.2018.1500032. [Epub ahead of print]


Response to Letter "Prediction of Falls in Subjects Suffering From Parkinson Disease, Multiple Sclerosis, and Stroke: Methodologic Issues".

Cattaneo D, Gervasoni E, Pupillo E, Bianchi E, Agostini M, Rovaris M, Aprile I, Montesano A, Beghi E.

Arch Phys Med Rehabil. 2018 Aug;99(8):1688-1689. doi: 10.1016/j.apmr.2018.04.001. No abstract available.


Cardiac autonomic function during postural changes and exercise in people with multiple sclerosis: A cross-sectional study.

Gervasoni E, Bove M, Sinatra M, Grosso C, Rovaris M, Cattaneo D, Merati G.

Mult Scler Relat Disord. 2018 Aug;24:85-90. doi: 10.1016/j.msard.2018.06.003. Epub 2018 Jun 27.


Intraindividual and Interindividual Variability of Olanzapine Trough Concentrations in Patients Treated With the Long-Acting Injectable Formulation.

Baldelli S, Mauri MC, Di Pace C, Paletta S, Reggiori A, Rovera C, Clementi E, Cattaneo D.

J Clin Psychopharmacol. 2018 Aug;38(4):365-369. doi: 10.1097/JCP.0000000000000913.


Residual Peripheral Blood CD26+ Leukemic Stem Cells in Chronic Myeloid Leukemia Patients During TKI Therapy and During Treatment-Free Remission.

Bocchia M, Sicuranza A, Abruzzese E, Iurlo A, Sirianni S, Gozzini A, Galimberti S, Aprile L, Martino B, Pregno P, Sorà F, Alunni G, Fava C, Castagnetti F, Puccetti L, Breccia M, Cattaneo D, Defina M, Mulas O, Baratè C, Caocci G, Sica S, Gozzetti A, Luciano L, Crugnola M, Annunziata M, Tiribelli M, Pacelli P, Ferrigno I, Usala E, Sgherza N, Rosti G, Bosi A, Raspadori D.

Front Oncol. 2018 May 30;8:194. doi: 10.3389/fonc.2018.00194. eCollection 2018.


Clinical and genetic determinants of nevirapine plasma trough concentration.

Giacomelli A, Rusconi S, Falvella FS, Oreni ML, Cattaneo D, Cozzi V, Renisi G, Monge E, Cheli S, Clementi E, Riva A, Galli M, Ridolfo AL.

SAGE Open Med. 2018 Jun 5;6:2050312118780861. doi: 10.1177/2050312118780861. eCollection 2018.


How relevant are the drug-drug interactions between antiretroviral boosted-based regimens and calcium channel blockers in real life?

Cattaneo D, Formenti T, Astuti N, Meraviglia P, Ridolfo A, Gervasoni C.

J Antimicrob Chemother. 2018 Aug 1;73(8):2271-2273. doi: 10.1093/jac/dky139. No abstract available.


The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting.

De Stefano V, Rocca B, Tosetto A, Soldati D, Petrucci G, Beggiato E, Bertozzi I, Betti S, Carli G, Carpenedo M, Cattaneo D, Cavalca V, Dragani A, Elli E, Finazzi G, Iurlo A, Lanzarone G, Lissandrini L, Palandri F, Paoli C, Rambaldi A, Ranalli P, Randi ML, Ricco A, Rossi E, Ruggeri M, Specchia G, Timillero A, Turnu L, Vianelli N, Vannucchi AM, Rodeghiero F, Patrono C.

Blood Cancer J. 2018 Jun 1;8(6):49. doi: 10.1038/s41408-018-0078-3.


Burden of Exposure to Potential Interactions Between Antiretroviral and Non-Antiretroviral Medications in a Population of HIV-Positive Patients Aged 50 Years or Older.

Ranzani A, Oreni L, Agrò M, van den Bogaart L, Milazzo L, Giacomelli A, Cattaneo D, Gervasoni C, Ridolfo AL.

J Acquir Immune Defic Syndr. 2018 Jun 1;78(2):193-201. doi: 10.1097/QAI.0000000000001653.


Development and Validation of a Chromatographic Ultraviolet Method for the Quantification of Isavuconazole in Human Plasma Samples.

Cozzi V, Baldelli S, Castoldi S, Clementi E, Cattaneo D.

Ther Drug Monit. 2018 Aug;40(4):512-514. doi: 10.1097/FTD.0000000000000523. No abstract available.


High isavuconazole plasma levels in a patient with possible invasive pulmonary aspergillosis and cirrhosis.

Arsiè E, Piconi S, Iavarone M, Cozzi V, Lampertico P, Cattaneo D.

Eur J Clin Pharmacol. 2018 Aug;74(8):1089-1090. doi: 10.1007/s00228-018-2462-0. Epub 2018 Apr 18. No abstract available.


Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis.

Caocci G, Mulas O, Annunziata M, Luciano L, Bonifacio M, Orlandi EM, Pregno P, Galimberti S, Russo Rossi A, Abruzzese E, Iurlo A, Martino B, Sgherza N, Binotto G, Castagnetti F, Gozzini A, Fozza C, Bocchia M, Sicuranza A, Stagno F, Efficace F, Usala E, De Gregorio F, Scaffidi L, Elena C, Pirillo F, Baratè C, Trawinska MM, Cattaneo D, Labate C, Gugliotta G, Molica M, Specchia G, La Nasa G, Foà R, Breccia M.

Am J Hematol. 2018 Jul;93(7):E159-E161. doi: 10.1002/ajh.25102. Epub 2018 Apr 28. No abstract available.


Effects of motor rehabilitation on mobility and brain plasticity in multiple sclerosis: a structural and functional MRI study.

Tavazzi E, Bergsland N, Cattaneo D, Gervasoni E, Laganà MM, Dipasquale O, Grosso C, Saibene FL, Baglio F, Rovaris M.

J Neurol. 2018 Jun;265(6):1393-1401. doi: 10.1007/s00415-018-8859-y. Epub 2018 Apr 7.


Physiotherapeutic interventions in multiple sclerosis across Europe: Regions and other factors that matter.

Martinková P, Freeman J, Drabinová A, Erosheva E, Cattaneo D, Jonsdottir J, Baert I, Smedal T, Romberg A, Feys P, Alves-Guerreiro J, Habek M, Henze T, Medina CS, Beiske A, Van Asch P, Bakalidou D, Salcı Y, Dimitrova EN, Pavlíková M, Řasová K.

Mult Scler Relat Disord. 2018 May;22:59-67. doi: 10.1016/j.msard.2018.03.005. Epub 2018 Mar 14.


Heterogeneity among splanchnic vein thrombosis associated with myeloproliferative neoplasms.

Cattaneo D, Gianelli U, Bianchi P, Cortelezzi A, Iurlo A.

Eur J Intern Med. 2018 Jun;52:e25-e26. doi: 10.1016/j.ejim.2018.03.009. Epub 2018 Mar 20. No abstract available.


How does strength training and balance training affect gait and fatigue in patients with Multiple Sclerosis? A study protocol of a randomized controlled trial.

Callesen J, Cattaneo D, Brincks J, Dalgas U.

NeuroRehabilitation. 2018;42(2):131-142. doi: 10.3233/NRE-172238.


Selective serotonin reuptake inhibitors' passage into human milk of lactating women.

Pogliani L, Baldelli S, Cattaneo D, Pileri P, Clementi E, Cetin I, Zuccotti G.

J Matern Fetal Neonatal Med. 2018 May 6:1-6. doi: 10.1080/14767058.2018.1455180. [Epub ahead of print]


First Evaluation of Infrared Thermography as a Tool for the Monitoring of Udder Health Status in Farms of Dairy Cows.

Zaninelli M, Redaelli V, Luzi F, Bronzo V, Mitchell M, Dell'Orto V, Bontempo V, Cattaneo D, Savoini G.

Sensors (Basel). 2018 Mar 14;18(3). pii: E862. doi: 10.3390/s18030862.


Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms.

De Stefano V, Carobbio A, Di Lazzaro V, Guglielmelli P, Iurlo A, Finazzi MC, Rumi E, Cervantes F, Elli EM, Randi ML, Griesshammer M, Palandri F, Bonifacio M, Hernandez-Boluda JC, Cacciola R, Miroslava P, Carli G, Beggiato E, Ellis MH, Musolino C, Gaidano G, Rapezzi D, Tieghi A, Lunghi F, Loscocco GG, Cattaneo D, Cortelezzi A, Betti S, Rossi E, Finazzi G, Censori B, Cazzola M, Bellini M, Arellano-Rodrigo E, Bertozzi I, Sadjadian P, Vianelli N, Scaffidi L, Gomez M, Cacciola E, Vannucchi AM, Barbui T.

Blood Cancer J. 2018 Feb 28;8(3):25. doi: 10.1038/s41408-018-0048-9.


Potential associations between atazanavir exposure and clinical outcome: a pharmacokinetic sub-study from the MODAt randomized trial.

Colella E, Cattaneo D, Galli L, Baldelli S, Clementi E, Galli M, Lazzarin A, Castagna A, Rusconi S, Spagnuolo V.

New Microbiol. 2018 Apr;41(2):106-111. Epub 2018 Mar 2.


Dolutegravir and metformin: a clinically relevant or just a pharmacokinetic interaction?

Cattaneo D, Resnati C, Rizzardini G, Gervasoni C.

AIDS. 2018 Feb 20;32(4):532-533. doi: 10.1097/QAD.0000000000001720. No abstract available.


Low-Dose Ponatinib in Intolerant Chronic Myeloid Leukemia Patients: A Safe and Effective Option.

Iurlo A, Cattaneo D, Orofino N, Bucelli C, Molica M, Breccia M.

Clin Drug Investig. 2018 May;38(5):475-476. doi: 10.1007/s40261-018-0623-7. No abstract available.


Comparison of the ARK Immunoassay With High-Performance Liquid Chromatography With Ultraviolet Detection for Therapeutic Drug Monitoring of Linezolid.

Castoldi S, Cozzi V, Baldelli S, Fucile S, Clementi E, Cattaneo D.

Ther Drug Monit. 2018 Feb;40(1):140-143. doi: 10.1097/FTD.0000000000000473.


Development of a Machine Vision Method for the Monitoring of Laying Hens and Detection of Multiple Nest Occupations.

Zaninelli M, Redaelli V, Luzi F, Mitchell M, Bontempo V, Cattaneo D, Dell'Orto V, Savoini G.

Sensors (Basel). 2018 Jan 5;18(1). pii: E132. doi: 10.3390/s18010132.


The relevance of drug-drug interactions in clinical practice: the case of concomitant boosted protease inhibitors plus alpha-1 blocker administration.

Gervasoni C, Resnati C, Formenti T, Fossati A, Minisci D, Meraviglia P, Cattaneo D.

Antivir Ther. 2018;23(5):467-469. doi: 10.3851/IMP3214. No abstract available.


Psychoactive drugs and HIV: are we sure to treat our patients adequately?

Cattaneo D, Rizzardini G, Gervasoni C.

AIDS. 2018 Jan 2;32(1):127-128. doi: 10.1097/QAD.0000000000001656. No abstract available.


Comparison of the Arktm Immunoassay With Hplc-Uv for Therapeutic Drug Monitoring of Linezolid.

Castoldi S, Cozzi V, Baldelli S, Fucile S, Clementi E, Cattaneo D.

Ther Drug Monit. 2017 Dec 4. doi: 10.1097/FTD.0000000000000473. [Epub ahead of print]


Can We Rely on AGNP Therapeutic Targets Also For LAI Antipsychotics?

Baldelli S, Clementi E, Cattaneo D.

Pharmacopsychiatry. 2018 Nov;51(6):270-271. doi: 10.1055/s-0043-122603. Epub 2017 Nov 27.


Supplemental Content

Loading ...
Support Center